Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.

International journal of cancer - 15 Sept 2016

van den Heuvel Tim R A, Wintjens Dion S J, Jeuring Steven F G, Wassink Maartje H H, Romberg-Camps Marielle J L, Oostenbrug Liekele E, Sanduleanu Silvia, Hameeteman Wim H, Zeegers Maurice P, Masclee Ad A, Jonkers Daisy M, Pierik Marie J

Abstract excerpt

The management of inflammatory bowel disease (IBD) has changed since the mid-1990s (e.g., use of thiopurines/anti-TNFα agents, improved surveillance programs), possibly affecting cancer risk. To establish current cancer risk in IBD, updates are warranted from cohorts covering this time span, and detailed enough to study associations with phenotype and medication. We studied intestinal-, extra-intestinal- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Follow-Up Studies
Share to Immunosuppression Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Inflammatory Bowel Diseases

Share to Neoplasms

Share to Netherlands

Share to Population Surveillance

Source

Identifiers

PMID: 27170593
DOI: 10.1002/ijc.30183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.PMID 27170593Read ↗

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.Semantic proximity Read ↗

Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.Semantic proximity Read ↗

Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).Semantic proximity Read ↗

Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin CancerSemantic proximity Read ↗

Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands.Semantic proximity Read ↗

Clinical Phenotype and Disease Course of Inflammatory Bowel Disease: A Comparison Between Sporadic and Familial Cases.Semantic proximity Read ↗

Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?Semantic proximity Read ↗

The burden of inflammatory bowel disease in Europe.Semantic proximity Read ↗

Inflammatory bowel disease and risk of more than 1500 comorbidities: A disease-wide pre- and post-diagnostic phenomic association studySemantic proximity Read ↗

Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal MicroecologySemantic proximity Read ↗

Comparative Incidence of Inflammatory Bowel Disease in Different Age Groups in the United States.Semantic proximity Read ↗

Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.